Capital Royalty L.P. is pleased to announce it has raised capital to support its new healthcare private equity fund, Capital Royalty Partners, L.P. Investors in the new fund reflect a diverse group of institutions including pension funds and insurance companies.

About Capital Royalty L.P.

Capital Royalty acquires healthcare-related royalty and revenue interests on approved products in the pharmaceutical, biotechnology, drug delivery, diagnostic and medical device sectors.

Charles Tate, Chairman of Capital Royalty L.P., has over 30 years of experience in private equity, merchant and investment banking. Jim Webster, Managing Partner, together with an experienced team of professionals, have over 60 years of combined experience in the healthcare and royalty sectors.

For more information on the advantages of royalty financing, please visit the Capital Royalty web site at www.capitalroyalty.com or contact hloveys@capitalroyalty.com.